経口COVID-19抗ウイルス剤のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Oral COVID-19 Antiviral Medicine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16270 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

経口COVID-19抗ウイルス剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の経口COVID-19抗ウイルス剤の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の経口COVID-19抗ウイルス剤の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 経口COVID-19抗ウイルス剤市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・錠剤、カプセル剤 用途別セグメントは次のように区分されます。 ・病院、クリニック 世界の経口COVID-19抗ウイルス剤市場の主要な市場プレーヤーは以下のとおりです。 ・Merck and Ridgeback 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、経口COVID-19抗ウイルス剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な経口COVID-19抗ウイルス剤メーカーの企業概要、2019年～2021年までの経口COVID-19抗ウイルス剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な経口COVID-19抗ウイルス剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別経口COVID-19抗ウイルス剤の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの経口COVID-19抗ウイルス剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での経口COVID-19抗ウイルス剤市場予測を収録しています。 ・第12、13、14章では、経口COVID-19抗ウイルス剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck and Ridgeback ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル剤 ・用途別分析2016年-2026年：病院、クリニック ・経口COVID-19抗ウイルス剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口COVID-19抗ウイルス剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口COVID-19抗ウイルス剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口COVID-19抗ウイルス剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口COVID-19抗ウイルス剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Oral COVID-19 Antiviral Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral COVID-19 Antiviral Medicine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Oral COVID-19 Antiviral Medicine market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Oral COVID-19 Antiviral Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablet
Capsule

Market segment by Application can be divided into
Hospital
Clinic

The key market players for global Oral COVID-19 Antiviral Medicine market are listed below:
Merck and Ridgeback

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oral COVID-19 Antiviral Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral COVID-19 Antiviral Medicine, with price, sales, revenue and global market share of Oral COVID-19 Antiviral Medicine from 2019 to 2021.
Chapter 3, the Oral COVID-19 Antiviral Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral COVID-19 Antiviral Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral COVID-19 Antiviral Medicine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oral COVID-19 Antiviral Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Oral COVID-19 Antiviral Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral COVID-19 Antiviral Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral COVID-19 Antiviral Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Oral COVID-19 Antiviral Medicine Market Size & Forecast
1.4.1 Global Oral COVID-19 Antiviral Medicine Sales in Value (2016-2026))
1.4.2 Global Oral COVID-19 Antiviral Medicine Sales in Volume (2016-2026)
1.4.3 Global Oral COVID-19 Antiviral Medicine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Oral COVID-19 Antiviral Medicine Production Capacity Analysis
1.5.1 Global Oral COVID-19 Antiviral Medicine Total Production Capacity (2016-2026)
1.5.2 Global Oral COVID-19 Antiviral Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral COVID-19 Antiviral Medicine Market Drivers
1.6.2 Oral COVID-19 Antiviral Medicine Market Restraints
1.6.3 Oral COVID-19 Antiviral Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Merck and Ridgeback
2.1.1 Merck and Ridgeback Details
2.1.2 Merck and Ridgeback Major Business
2.1.3 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product and Services
2.1.4 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oral COVID-19 Antiviral Medicine Sales by Manufacturer
3.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral COVID-19 Antiviral Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral COVID-19 Antiviral Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Oral COVID-19 Antiviral Medicine Manufacturer Market Share
3.4.2 Top 6 Oral COVID-19 Antiviral Medicine Manufacturer Market Share
3.5 Global Oral COVID-19 Antiviral Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral COVID-19 Antiviral Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral COVID-19 Antiviral Medicine Market Size by Region
4.1.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Oral COVID-19 Antiviral Medicine Revenue by Region (2016-2026)
4.2 North America Oral COVID-19 Antiviral Medicine Revenue (2016-2026)
4.3 Europe Oral COVID-19 Antiviral Medicine Revenue (2016-2026)
4.4 Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue (2016-2026)
4.5 South America Oral COVID-19 Antiviral Medicine Revenue (2016-2026)
4.6 Middle East and Africa Oral COVID-19 Antiviral Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Type (2016-2026)
5.2 Global Oral COVID-19 Antiviral Medicine Revenue by Type (2016-2026)
5.3 Global Oral COVID-19 Antiviral Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Application (2016-2026)
6.2 Global Oral COVID-19 Antiviral Medicine Revenue by Application (2016-2026)
6.3 Global Oral COVID-19 Antiviral Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral COVID-19 Antiviral Medicine Sales by Type (2016-2026)
7.2 North America Oral COVID-19 Antiviral Medicine Sales by Application (2016-2026)
7.3 North America Oral COVID-19 Antiviral Medicine Market Size by Country
7.3.1 North America Oral COVID-19 Antiviral Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral COVID-19 Antiviral Medicine Sales by Type (2016-2026)
8.2 Europe Oral COVID-19 Antiviral Medicine Sales by Application (2016-2026)
8.3 Europe Oral COVID-19 Antiviral Medicine Market Size by Country
8.3.1 Europe Oral COVID-19 Antiviral Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size by Region
9.3.1 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral COVID-19 Antiviral Medicine Sales by Type (2016-2026)
10.2 South America Oral COVID-19 Antiviral Medicine Sales by Application (2016-2026)
10.3 South America Oral COVID-19 Antiviral Medicine Market Size by Country
10.3.1 South America Oral COVID-19 Antiviral Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Oral COVID-19 Antiviral Medicine Market Size by Country
11.3.1 Middle East & Africa Oral COVID-19 Antiviral Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral COVID-19 Antiviral Medicine Typical Distributors
12.3 Oral COVID-19 Antiviral Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Oral COVID-19 Antiviral Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral COVID-19 Antiviral Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck and Ridgeback Basic Information, Manufacturing Base and Competitors
Table 4. Merck and Ridgeback Major Business
Table 5. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product and Services
Table 6. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Oral COVID-19 Antiviral Medicine Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Oral COVID-19 Antiviral Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Oral COVID-19 Antiviral Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Oral COVID-19 Antiviral Medicine Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Oral COVID-19 Antiviral Medicine Production Site of Key Manufacturer
Table 12. Oral COVID-19 Antiviral Medicine New Entrant and Capacity Expansion Plans
Table 13. Oral COVID-19 Antiviral Medicine Mergers & Acquisitions in the Past Five Years
Table 14. Global Oral COVID-19 Antiviral Medicine Sales by Region (2016-2021e) & (K Units)
Table 15. Global Oral COVID-19 Antiviral Medicine Sales by Region (2021-2026) & (K Units)
Table 16. Global Oral COVID-19 Antiviral Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Oral COVID-19 Antiviral Medicine Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 19. Global Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 20. Global Oral COVID-19 Antiviral Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Oral COVID-19 Antiviral Medicine Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Oral COVID-19 Antiviral Medicine Price by Type (2016-2021e) & (US$/Unit)
Table 23. Global Oral COVID-19 Antiviral Medicine Price by Type (2021-2026) & (US$/Unit)
Table 24. Global Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 25. Global Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 26. Global Oral COVID-19 Antiviral Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Oral COVID-19 Antiviral Medicine Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Oral COVID-19 Antiviral Medicine Price by Application (2016-2021e) & (US$/Unit)
Table 29. Global Oral COVID-19 Antiviral Medicine Price by Application (2021-2026) & (US$/Unit)
Table 30. North America Oral COVID-19 Antiviral Medicine Sales by Country (2016-2021e) & (K Units)
Table 31. North America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units)
Table 32. North America Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Oral COVID-19 Antiviral Medicine Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 35. North America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 36. North America Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 37. North America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 38. Europe Oral COVID-19 Antiviral Medicine Sales by Country (2016-2021e) & (K Units)
Table 39. Europe Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units)
Table 40. Europe Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Oral COVID-19 Antiviral Medicine Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 43. Europe Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 44. Europe Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 45. Europe Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 46. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Region (2016-2021e) & (K Units)
Table 47. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Region (2021-2026) & (K Units)
Table 48. Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 51. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 52. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 53. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 54. South America Oral COVID-19 Antiviral Medicine Sales by Country (2016-2021e) & (K Units)
Table 55. South America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units)
Table 56. South America Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Oral COVID-19 Antiviral Medicine Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 59. South America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 60. South America Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 61. South America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Country (2016-2021e) & (K Units)
Table 63. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Type (2016-2021e) & (K Units)
Table 67. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Application (2016-2021e) & (K Units)
Table 69. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Oral COVID-19 Antiviral Medicine Typical Distributors
Table 73. Oral COVID-19 Antiviral Medicine Typical Customers
List of Figures
Figure 1. Oral COVID-19 Antiviral Medicine Picture
Figure 2. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Capsule
Figure 5. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Oral COVID-19 Antiviral Medicine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Oral COVID-19 Antiviral Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Oral COVID-19 Antiviral Medicine Sales (2016-2026) & (K Units)
Figure 11. Global Oral COVID-19 Antiviral Medicine Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Oral COVID-19 Antiviral Medicine Production Capacity (2016-2026) & (K Units)
Figure 13. Global Oral COVID-19 Antiviral Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Oral COVID-19 Antiviral Medicine Market Drivers
Figure 15. Oral COVID-19 Antiviral Medicine Market Restraints
Figure 16. Oral COVID-19 Antiviral Medicine Market Trends
Figure 17. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Manufacturer in 2020
Figure 18. Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Manufacturer in 2020
Figure 19. Oral COVID-19 Antiviral Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Oral COVID-19 Antiviral Medicine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Oral COVID-19 Antiviral Medicine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Region (2016-2026)
Figure 23. Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Region (2016-2026)
Figure 24. North America Oral COVID-19 Antiviral Medicine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Oral COVID-19 Antiviral Medicine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue (2016-2026) & (USD Million)
Figure 27. South America Oral COVID-19 Antiviral Medicine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue (2016-2026) & (USD Million)
Figure 29. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2016-2026)
Figure 30. Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Type (2016-2026)
Figure 31. Global Oral COVID-19 Antiviral Medicine Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 33. Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Application (2016-2026)
Figure 34. Global Oral COVID-19 Antiviral Medicine Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2016-2026)
Figure 36. North America Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 37. North America Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2016-2026)
Figure 38. North America Oral COVID-19 Antiviral Medicine Revenue Market Share by Country (2016-2026)
Figure 39. United States Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2016-2026)
Figure 43. Europe Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 44. Europe Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2016-2026)
Figure 45. Europe Oral COVID-19 Antiviral Medicine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Oral COVID-19 Antiviral Medicine Revenue Market Share by Region (2016-2026)
Figure 55. China Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2016-2026)
Figure 62. South America Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 63. South America Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2016-2026)
Figure 64. South America Oral COVID-19 Antiviral Medicine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Oral COVID-19 Antiviral Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---